Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Build a flexible savings plan focused on health costs by setting aside small, regular amounts and automating transfers. A proactive fund can soften the impact of medical surprises.
14,360 articlesA major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
When a Harmonic director sold 4,300 shares, it sparked questions about the stock’s outlook. This guide breaks down in...
As tax policy and market conditions shift, a growing number of retirees with $2 million in retirement accounts seek g...
Vitalik Buterin announced a recalibration of the Ethereum Foundation's role, underscoring a shift toward a smaller, p...
The European Union plans to fund its next long-term budget, but real change goes beyond adding taxes. This article ex...
Best Buy surprised investors with a solid earnings beat and improving margins, sending the stock higher. This article...
As SM Energy reports Q4 2025 results, investors gain a window into the company's production mix, costs, and capital p...
Upstart gained fame for its AI-driven lending, but the real stakes for investors lie in who funds the loans. This art...
Two popular bank-focused ETFs offer different paths to tap the U.S. financial sector. This piece breaks down broad ba...
Investors are watching Apple’s latest Siri reveal to see if it marks a meaningful AI leap or just another upgrade. Th...
When a CFO sells company shares worth millions, investors naturally wonder what it means for stock risk and future re...
Markets await Kevin Warsh’s first Fed policy decision amid oil price movements and a fragile housing sector. This rep...